Center for Scientific Review; Notice of Closed Meetings, 25135-25136 [2014-10016]
Download as PDF
Federal Register / Vol. 79, No. 85 / Friday, May 2, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Gene Therapy.
Date: May 16, 2014.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Dominique Lorang-Leins,
Ph.D., Scientific Review Officer, National
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Room 5108,
MSC 7766, Bethesda, MD 20892,
301.326.9721, Lorangd@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Auditory Neuroscience.
Date: May 27–28, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 28, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–10017 Filed 5–1–14; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
00:23 May 02, 2014
Jkt 232001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; NHLBI
Systems Biology.
Date: May 27–28, 2014.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9497, zouai@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Lung Injury, Repair, and Remodeling
Study Section.
Date: June 2, 2014.
Time: 7:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Guest Suites Santa
Monica, 1707 Fourth Street, Santa Monica,
CA 90401.
Contact Person: Ghenima Dirami, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7814, Bethesda, MD 20892, 240–498–
7546, diramig@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Psychosocial Risk and Disease Prevention
Study Section.
Date: June 2–3, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Stacey FitzSimmons,
Ph.D., MPH, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
25135
MSC 7808, Bethesda, MD 20892, 301–451–
9956, fitzsimmonss@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;,
Behavioral Medicine, Interventions and
Outcomes Study Section.
Date: June 2–3, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Loews Annapolis Hotel, 126 West
Street, Annapolis, MD 21401.
Contact Person: Lee S Mann, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7848, Bethesda, MD 20892, 301–435–
0677, mannl@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Clinical, Integrative and Molecular
Gastroenterology Study Section.
Date: June 2, 2014.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Raleigh Durham Airport, @
Research Triangle Park, 4810 Page Creek
Lane, Durham,, NC 27703.
Contact Person: Mushtaq A Khan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2176,
MSC 7818, Bethesda, MD 20892, 301–435–
1778, khanm@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Bioengineering,
Technology and Surgical Sciences Study
Section.
Date: June 2–3, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Long Beach Hotel, 111
East Ocean Blvd., Long Beach, CA 90802.
Contact Person: Khalid Masood, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5120,
MSC 7854, Bethesda, MD 20892, 301–435–
2392, masoodk@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Development—2
Study Section.
Date: June 2–3, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Long Beach Hotel, 111
East Ocean Blvd., Long Beach, CA 90802.
Contact Person: Rass M Shayiq, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, (301) 435–
2359, shayiqr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Psychosocial Risk and Disease Prevention.
Date: June 2, 2014.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\02MYN1.SGM
02MYN1
25136
Federal Register / Vol. 79, No. 85 / Friday, May 2, 2014 / Notices
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Kristen Prentice, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, 301–496–
0726, prenticekj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 28, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–10016 Filed 5–1–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee
on the Validation of Alternative
Methods; Notice of Public Meeting;
Request for Public Input
The Interagency Coordinating
Committee on the Validation of
Alternative Methods (ICCVAM) will
hold a public forum to share
information and facilitate direct
communication of ideas and suggestions
from stakeholders. Interested persons
may attend in person or via
teleconference and time will be set aside
for public statements and questions on
the topics discussed.
DATES: Meeting: June 25, 2014, 1:00 p.m.
to approximately 4:00 p.m. Eastern
Daylight Time (EDT).
Registration for Meeting: May 7, 2014
through June 11, 2014.
Deadline for Submission of Oral
Public Statements: June 11, 2014
ADDRESSES:
Meeting Location: William H. Natcher
Conference Center, National Institutes of
Health, Bethesda, MD 20892.
Meeting Web page: The preliminary
agenda, registration, and other meeting
materials are at https://ntp.niehs.nih.gov/
go/41490.
FOR FURTHER INFORMATION CONTACT: Dr.
Warren S. Casey, Director, National
Toxicology Program Interagency Center
for the Evaluation of Alternative
Toxicological Methods (NICEATM);
email: warren.casey@nih.gov; telephone:
(919) 316–4729.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM promotes the
development and validation of chemical
safety testing methods that protect
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
00:23 May 02, 2014
Jkt 232001
human health and the environment
while replacing, reducing, or refining
animal use.
In 2013, ICCVAM published a draft
plan (https://ntp.niehs.nih.gov/go/
iccvam-mission) focused on addressing
advances in toxicological science while
reflecting the needs and priorities of its
partner regulatory agencies and
improving communications with the
public, including holding public forums
to facilitate direct communication with
its stakeholders.
The first of these forums will be held
on June 25, 2014, at the National
Institutes of Health in Bethesda, MD.
The meeting will begin with
presentations by NICEATM and
ICCVAM members on current activities
including (1) evaluation of nonanimal
methods to identify potential skin
sensitizers and eye irritants, (2)
interactions with international
validation organizations, and (3)
revisions to ICCVAM processes.
Following each presentation, there will
be an opportunity for attendees to ask
questions. The agenda also includes
time for attendees to make public oral
statements to inform ICCVAM on topics
relevant to its mission and current
activities.
Preliminary Agenda and Other
Meeting Information: The preliminary
agenda, ICCVAM roster, background
materials, and public statements
submitted prior to the meeting will be
posted at https://ntp.niehs.nih.gov/go/
41490 to allow participation by remote
attendees. Public statements will be
distributed to NICEATM and ICCVAM
members.
Meeting and Registration: This
meeting is open to the public with time
scheduled for oral public statements
and for questions following ICCVAM’s
and NICEATM’s presentations;
attendance is limited only by the space
available. Participants are encouraged to
register at https://ntp.niehs.nih.gov/go/
41490 by June 11, 2014 to facilitate
planning for appropriate meeting space.
Interested individuals are encouraged to
visit this Web page to stay abreast of the
most current meeting information.
Visitor and security information is
available at https://www.nih.gov/about/
visitor/index.htm. Individuals with
disabilities who need accommodation to
participate in this event should contact
Dr. Elizabeth Maull at phone: (919) 316–
4668 or email: maull@niehs.nih.gov.
TTY users should contact the Federal
TTY Relay Service at 800–877–8339.
Requests should be made at least five
business days in advance of the event.
Request for Oral Public Statements:
Time will be allotted during the meeting
for oral public statements with
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
associated slides relevant to ICCVAM’s
mission and current activities. The
number and length of presentations may
be limited based on available time.
Speakers are asked to submit a copy of
their statement and/or associated slides
by June 11, 2014 to allow time for
posting to the meeting page and review
by NICEATM and ICCVAM members.
Submitters will be identified by their
name and affiliation and/or sponsoring
organization, if applicable. Persons
submitting public statements and/or
associated slides should include their
name, affiliation (if any), mailing
address, telephone, email, and
sponsoring organization (if any) with
the document. Registration for oral
public statements will be available
onsite, although onsite registration and
time allotted for these statements may
be limited based on the number of
individuals who register for comments
and available time.
For remote participation, 50
teleconference lines will be available on
a first-come, first-served basis. The
teleconference access number will be
provided to registrants by email prior to
the meeting.
Responses to this notice are
voluntary. No proprietary, classified,
confidential, or sensitive information
should be included in comments
submitted in response to this notice or
during the meeting. This request for
input is for planning purposes only and
is not a solicitation for applications or
an obligation on the part of the U.S.
Government to provide support for any
ideas identified in response to the
request. Please note that the U.S.
Government will not pay for the
preparation of any information
submitted or for its use of that
information.
Background Information on ICCVAM
and NICEATM: ICCVAM is an
interagency committee composed of
representatives from 15 Federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability and promotes
the scientific validation and regulatory
acceptance of testing methods that both
more accurately assess the safety and
hazards of chemicals and products and
replace, reduce, or refine (enhance
animal well-being and lessen or avoid
pain and distress) animal use.
The ICCVAM Authorization Act of
2000 (42 U.S.C. 285l–3) establishes
ICCVAM as a permanent interagency
committee of the NIEHS and provides
E:\FR\FM\02MYN1.SGM
02MYN1
Agencies
[Federal Register Volume 79, Number 85 (Friday, May 2, 2014)]
[Notices]
[Pages 25135-25136]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10016]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; NHLBI Systems Biology.
Date: May 27-28, 2014.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD
20892, 301-408-9497, zouai@csr.nih.gov.
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group; Lung Injury, Repair, and Remodeling Study
Section.
Date: June 2, 2014.
Time: 7:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Guest Suites Santa Monica, 1707 Fourth Street,
Santa Monica, CA 90401.
Contact Person: Ghenima Dirami, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122, MSC 7814, Bethesda, MD
20892, 240-498-7546, diramig@csr.nih.gov.
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; Psychosocial Risk and Disease Prevention
Study Section.
Date: June 2-3, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Stacey FitzSimmons, Ph.D., MPH, Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114, MSC 7808, Bethesda, MD
20892, 301-451-9956, fitzsimmonss@csr.nih.gov.
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group;, Behavioral Medicine, Interventions and
Outcomes Study Section.
Date: June 2-3, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Loews Annapolis Hotel, 126 West Street, Annapolis, MD
21401.
Contact Person: Lee S Mann, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3186, MSC 7848, Bethesda, MD 20892, 301-435-
0677, mannl@csr.nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group; Clinical, Integrative and Molecular
Gastroenterology Study Section.
Date: June 2, 2014.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Raleigh Durham Airport, @ Research Triangle Park,
4810 Page Creek Lane, Durham,, NC 27703.
Contact Person: Mushtaq A Khan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2176, MSC 7818, Bethesda, MD
20892, 301-435-1778, khanm@csr.nih.gov.
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Bioengineering, Technology
and Surgical Sciences Study Section.
Date: June 2-3, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Long Beach Hotel, 111 East Ocean Blvd., Long
Beach, CA 90802.
Contact Person: Khalid Masood, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5120, MSC 7854, Bethesda, MD 20892, 301-435-
2392, masoodk@csr.nih.gov.
Name of Committee: Cell Biology Integrated Review Group;
Development--2 Study Section.
Date: June 2-3, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Long Beach Hotel, 111 East Ocean Blvd., Long
Beach, CA 90802.
Contact Person: Rass M Shayiq, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institute of Health, 6701
Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD 20892, (301) 435-
2359, shayiqr@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Psychosocial Risk and Disease Prevention.
Date: June 2, 2014.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 25136]]
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Kristen Prentice, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD
20892, 301-496-0726, prenticekj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 28, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-10016 Filed 5-1-14; 8:45 am]
BILLING CODE 4140-01-P